Douglas J. Pitera

6.0k total citations · 2 hit papers
8 papers, 3.0k citations indexed

About

Douglas J. Pitera is a scholar working on Molecular Biology, Pharmacology and Biomedical Engineering. According to data from OpenAlex, Douglas J. Pitera has authored 8 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Pharmacology and 1 paper in Biomedical Engineering. Recurrent topics in Douglas J. Pitera's work include Plant biochemistry and biosynthesis (7 papers), Microbial Natural Products and Biosynthesis (6 papers) and Microbial Metabolic Engineering and Bioproduction (6 papers). Douglas J. Pitera is often cited by papers focused on Plant biochemistry and biosynthesis (7 papers), Microbial Natural Products and Biosynthesis (6 papers) and Microbial Metabolic Engineering and Bioproduction (6 papers). Douglas J. Pitera collaborates with scholars based in United States. Douglas J. Pitera's co-authors include Jay D. Keasling, Jack D. Newman, Vincent J. J. Martin, Sydnor T. Withers, Brian F. Pfleger, Christopher J. Paddon, Christina D. Smolke, Kirsten R. Benjamin, Frank X. Woolard and Derek McPhee and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Biotechnology and Applied and Environmental Microbiology.

In The Last Decade

Douglas J. Pitera

8 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Engineering a mevalonate pathway in Escherichia coli for production of terpenoids

2003 1.3k citations Vincent J. J. Martin, Douglas J. Pitera et al. Nature Biotechnology profile →
Production of amorphadiene in yeast, and its conversion to dihydroartemisinic acid, precursor to the antimalarial agent artemisinin

2012 551 citations Patrick J. Westfall, Douglas J. Pitera et al. Proceedings of the National Academy of Sciences profile →

Peers

Countries citing papers authored by Douglas J. Pitera

Since Specialization

Citations

This map shows the geographic impact of Douglas J. Pitera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas J. Pitera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas J. Pitera more than expected).

Fields of papers citing papers by Douglas J. Pitera

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas J. Pitera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas J. Pitera. The network helps show where Douglas J. Pitera may publish in the future.

Co-authorship network of co-authors of Douglas J. Pitera

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas J. Pitera. A scholar is included among the top collaborators of Douglas J. Pitera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas J. Pitera. Douglas J. Pitera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

#	Work	Indexed citations
1	Clean manufacturing powered by biology: how Amyris has deployed technology and aims to do it better 2020 ·Journal of Industrial Microbiology & Biotechnology ·Paul W. Hill, Kirsten R. Benjamin, Binita Bhattacharjee, Fernando J. Castillo-García, (unknown), (unknown), Abhishek Murarka, Douglas J. Pitera, (unknown), (unknown), (unknown)	16
2	Production of amorphadiene in yeast, and its conversion to dihydroartemisinic acid, precursor to the antimalarial agent artemisinin breakdown → 2012 ·Proceedings of the National Academy of Sciences ·Patrick J. Westfall, Douglas J. Pitera, (unknown), Diana G. Eng, Frank X. Woolard, Rika Regentin, Tizita Horning, Hiroko Tsuruta, (unknown), Andrew E. Owens, (unknown), (unknown), Kirsten R. Benjamin, Jay D. Keasling, Michael D. Leavell, Derek McPhee, Neil S. Renninger, Jack D. Newman, Christopher J. Paddon	551
3	Application of Functional Genomics to Pathway Optimization for Increased Isoprenoid Production 2008 ·Applied and Environmental Microbiology ·(unknown), Douglas J. Pitera, Brian F. Pfleger, Jay D. Keasling	145
4	Microbial sensors for small molecules: Development of a mevalonate biosensor 2006 ·Metabolic Engineering ·Brian F. Pfleger, Douglas J. Pitera, Jack D. Newman, Vincent J. J. Martin, Jay D. Keasling	69
5	High‐level production of amorpha‐4,11‐diene in a two‐phase partitioning bioreactor of metabolically engineered Escherichia coli 2006 ·Biotechnology and Bioengineering ·Jack D. Newman, Jessica Marshall, Michelle C. Y. Chang, Farnaz Nowroozi, (unknown), Douglas J. Pitera, Karyn L. Newman, Jay D. Keasling	186
6	Combinatorial engineering of intergenic regions in operons tunes expression of multiple genes 2006 ·Nature Biotechnology ·Brian F. Pfleger, Douglas J. Pitera, Christina D. Smolke, Jay D. Keasling	416
7	Balancing a heterologous mevalonate pathway for improved isoprenoid production in Escherichia coli 2006 ·Metabolic Engineering ·Douglas J. Pitera, Christopher J. Paddon, Jack D. Newman, Jay D. Keasling	344
8	Engineering a mevalonate pathway in Escherichia coli for production of terpenoids breakdown → 2003 ·Nature Biotechnology ·Vincent J. J. Martin, Douglas J. Pitera, Sydnor T. Withers, Jack D. Newman, Jay D. Keasling	1314

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact